Front Barnett Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.75M | Hold |
3,255
| – | – | 0.21% | 49 |
|
|
2023
Q2 | $1.53M | Buy |
3,255
+100
| +3% | +$41.9K | 0.17% | 52 |
|
|
2023
Q1 | $1.08M | Sell |
3,155
-4
| -0.1% | -$1.35K | 0.13% | 66 |
|
|
2022
Q4 | $1.16M | Sell |
3,159
-25
| -0.8% | -$8.86K | 0.15% | 64 |
|
|
2022
Q3 | $1.03M | Hold |
3,184
| – | – | 0.14% | 63 |
|
|
2022
Q2 | $1.03M | Sell |
3,184
-20
| -0.6% | -$6K | 0.13% | 66 |
|
|
2022
Q1 | $918K | Buy |
3,204
+4
| +0.1% | +$1.03K | 0.09% | 75 |
|
|
2021
Q4 | $884K | Sell |
3,200
-105
| -3% | -$26.6K | 0.08% | 76 |
|
|
2021
Q3 | $764K | Hold |
3,305
| – | – | 0.08% | 78 |
|
|
2021
Q2 | $759K | Sell |
3,305
-100
| -3% | -$20.1K | 0.08% | 78 |
|
|
2021
Q1 | $636K | Hold |
3,405
| – | – | 0.07% | 75 |
|
|
2020
Q4 | $575K | Hold |
3,405
| – | – | 0.07% | 76 |
|
|
2020
Q3 | $504K | Hold |
3,405
| – | – | 0.07% | 75 |
|
|
2020
Q2 | $559K | Hold |
3,405
| – | – | 0.09% | 72 |
|
|
2020
Q1 | $472K | Hold |
3,405
| – | – | 0.09% | 78 |
|
|
2019
Q4 | $448K | Sell |
3,405
-35
| -1% | -$4.06K | 0.07% | 90 |
|
|
2019
Q3 | $385K | Hold |
3,440
| – | – | 0.06% | 91 |
|
|
2019
Q2 | $381K | Sell |
3,440
-65
| -2% | -$7.65K | 0.06% | 92 |
|
|
2019
Q1 | $455K | Sell |
3,505
-25
| -0.7% | -$3.04K | 0.07% | 89 |
|
|
2018
Q4 | $408K | Hold |
3,530
| – | – | 0.07% | 88 |
|
|
2018
Q3 | $379K | Hold |
3,530
| – | – | 0.06% | 94 |
|
|
2018
Q2 | $301K | Sell |
3,530
-55
| -2% | -$4.52K | 0.05% | 104 |
|
|
2018
Q1 | $277K | Sell |
3,585
-83
| -2% | -$6.68K | 0.05% | 106 |
|
|
2017
Q4 | $310K | Hold |
3,668
| – | – | 0.05% | 104 |
|
|
2017
Q3 | $314K | Hold |
3,668
| – | – | 0.06% | 103 |
|
|
2017
Q2 | $302K | Hold |
3,668
| – | – | 0.06% | 108 |
|
|
2017
Q1 | $309K | Hold |
3,668
| – | – | 0.06% | 105 |
|
|
2016
Q4 | $270K | Hold |
3,668
| – | – | 0.05% | 109 |
|
|
2016
Q3 | $294K | Hold |
3,668
| – | – | 0.06% | 103 |
|
|
2016
Q2 | $289K | Hold |
3,668
| – | – | 0.06% | 102 |
|
|
2016
Q1 | $264K | Hold |
3,668
| – | – | 0.05% | 106 |
|
|
2015
Q4 | $309K | Sell |
3,668
-97
| -3% | -$8.05K | 0.06% | 101 |
|
|
2015
Q3 | $315K | Buy |
3,765
+400
| +12% | +$33.8K | 0.07% | 95 |
|
|
2015
Q2 | $281K | Hold |
3,365
| – | – | 0.05% | 103 |
|
|
2015
Q1 | $244K | Hold |
3,365
| – | – | 0.04% | 106 |
|
|
2014
Q4 | $232K | Hold |
3,365
| – | – | 0.04% | 108 |
|
|
2014
Q3 | $218K | Hold |
3,365
| – | – | 0.04% | 109 |
|
|
2014
Q2 | $209K | Buy |
+3,365
| New | +$201K | 0.04% | 110 |
|
Other funds holding LLY
Front Barnett Associates's LLY Position: Q3 2023 in Review
Front Barnett Associates held its Eli Lilly (LLY) position steady in Q3 2023 at 3,255 shares worth $1.75M. The position accounts for 0.21% of the portfolio, ranked #49.
Front Barnett Associates first reported a position in LLY in Q2 2014 and has held it in 38 quarters since. 2,975 funds tracked by Wall St. Rank hold LLY as of Q3 2023.
- Front Barnett Associates held 3,255 shares of Eli Lilly worth $1.75M as of Q3 2023.
- Front Barnett Associates left its Eli Lilly share count unchanged in Q3 2023.
- Eli Lilly made up 0.21% of Front Barnett Associates's portfolio in Q3 2023, its #49 holding.
- Front Barnett Associates first reported a position in Eli Lilly in Q2 2014 and has held it in 38 quarters since.
- 2,975 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.
Based on Front Barnett Associates's 13F filing for Q3 2023, filed 13 Nov 2023.